José Baselga, a visionary leader in translational science and precision oncology and VHIO’s Founding Director. The international scientific cancer community,…
Laura Soucek, Principal Investigator of VHIO’s Mouse Models of Cancer Therapies Group, an ICREA Research Professor, and co-Founder and Executive…
Mariano F. Zacarías Fluck, Research Associate of VHIO’s Mouse Models of Cancer Therapies, and co-First Author of this present study….
In parallel with the European Society for Medical Oncology’s (ESMO) publication of its 2025 Vision, which builds on the core…
Incorporating experts from the seven European comprehensive cancer centers belonging to the Cancer Core Europe (CCE) Consortium, along with an…
The analysis of immune cells infiltrating cerebrospinal fluid enables the characterization of the tumor microenvironment in brain metastases. Findings reported today in…
Launched by the American Association for Cancer Research (AACR) back in 2015, the AACR Project Genomics Evidence Neoplasia Information Exchange…
The Horizon 2020 funded NoCANTher European Consortium*, coordinated by IMDEA Nanociencia, rolls out the clinical phase of the project. The…
Redirection of lymphocytes, via T-cell bispecific antibodies (TCBs) and chimeric antigen receptors (CARs), is already approved to treat some hematologic…
Findings from a comprehensive clinical, morphological, and molecular analysis of a cohort of 37 pregnant women with and without SARS-CoV-2…
Published this week as part of ecancer’s online educational program, renowned leaders in oncology including VHIO’s Enriqueta Felip, Principal Investigator…
Throughout 2020 and during the COVID-19 pandemic peaks, the Vall d’Hebron Institute of Oncology’s (VHIO) Research Unit for the Molecular…
